Rosenberg Andrew L
Department of Anesthesiology and Critical Care Medicine, University of Michigan, The University of Michigan Medical Center, 1H247 University Hospital, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA.
Respir Care Clin N Am. 2003 Dec;9(4):481-93. doi: 10.1016/s1078-5337(03)00036-4.
In a recent review of the data for fluid strategies and ARDS, fluid restriction or diuretic use was graded as "reasonably justifiable by available scientific evidence" and as "strongly supported by expert critical care opinion". Until the ARDS Network trial is published, only general guidelines regarding fluid management with or without specific vascular filling pressures from a pulmonary artery catheter can be made. Ultimately, the rationale for restricting fluid is to reduce hydrostatic pressures as much as possible. It seems most reasonable to maintain the lowest PAOP in ARDS patients that still maintains adequate circulating blood volume, mean arterial perfusion pressures, and cardiac output to provide sufficient oxygen delivery. Other clinical variables such as central venous pressure, urinary output, acid-base status, and lactate, serum urea nitrogen, and serum creatinine levels may help in judging the adequacy of a patient's intravascular volume, especially if central vascular pressure measurements are not available. Measures to reduce total body water, including flood restriction and diuretic use, seem to be of some benefit. Vasopressor use is especially important when systemic perfusion pressures are inadequate to maintain organ blood flow but should not be used to create supranormal levels of oxygen delivery.
在近期对液体治疗策略与急性呼吸窘迫综合征(ARDS)相关数据的综述中,液体限制或使用利尿剂被评定为“有现有科学证据合理支持”且“得到重症监护专家意见的强力支持”。在ARDS网络试验发表之前,只能制定关于液体管理的一般指南,无论是否采用肺动脉导管测量特定的血管充盈压。最终,限制液体的基本原理是尽可能降低静水压。在ARDS患者中维持能保持足够循环血容量、平均动脉灌注压和心输出量以提供充足氧输送的最低肺动脉闭塞压(PAOP)似乎最为合理。其他临床变量,如中心静脉压、尿量、酸碱状态以及乳酸、血清尿素氮和血清肌酐水平,可能有助于判断患者血管内容量是否充足,尤其是在无法测量中心血管压力时。包括液体限制和使用利尿剂在内的减少总体水含量的措施似乎有一定益处。当全身灌注压不足以维持器官血流时,使用血管升压药尤为重要,但不应将其用于创造超常的氧输送水平。